Preparation method of 2-hydroxy-3′-nitro-biphenyl-3-carboxylic acid_Kain Industrial Additive

Background and overview[1] Eltrombopag (trade name: Promacta) was developed by the British company GlaxoSmithKline. It was approved by the FDA for marketing in the United States in November 2008. It is an oral platelet production factor drug and a small molecule platelet production agent. It is a hormone receptor agonist that can interact with the…